Radical Reform of the R&D System

Will the 2017 budget address the health system crisis?

JOHANNESBURG, WEDNESDAY 1st MARCH: South Africa is facing an ongoing crisis in the public healthcare system. The 2015 General Household Survey indicated that seven in every ten households use public clinics and hospitals. However, when they access these facilities they are faced with dysfunction. Hospitals that leave patients on stretchers without being seen. Doctors in […]

Read More

SA and other BRICS must triple TB research funding

LIVERPOOL, THURSDAY 27th OCTOBER: In 2015 tuberculosis (TB) killed 1.8 million people on the planet. This is more than any other infectious disease, including HIV. Yet, investment in TB research remains disgracefully low. A new report by the United States-based Treatment Action Group (TAG) launched this week showed that total global funding for TB research […]

Read More

Activists tell WHO delegates: “We can’t afford to wait. Our people are dying”

GENEVA, WEDNESDAY 25th MAY 2016: Today activists from Universities Allied for Essential Medicines (UAEM),  the Treatment Action Campaign (TAC), Knowledge Ecology International (KEI), STOPAIDS, Youth STOPAIDS, Young Professionals Chronic Disease Network (YP-CDN), Commons Network, People’s Health Movement and Salud por Derecho demonstrated outside the 69th World Health Assembly, demanding delegates begin negotiations on a binding […]

Read More

SA Government takes Promising Stand on Patents

But public remains in the dark regarding stalled policy process The Fix the Patent Laws (FTPL) coalition welcomes recent public comments made by Minister of Trade and Industry Rob Davies and Minister of Health Dr Aaron Motsoaledi about patents and patent law in South Africa and in other developing countries. Earlier this month Minister Davies […]

Read More

Is the End to AIDS Just a PR Exercise?

Speech delivered by TAC General Secretary Anele Yawa at the opening of the HIV Clinicians conference on Wednesday 13th April 2016.  Conference delegates, people living with HIV, clinicians, friends and comrades. My name is Anele Yawa. I am the General Secretary of the Treatment Action Campaign and a user of the public healthcare system. The […]

Read More

Global Action Against Pharma Greed

We are not fooled: Global health activists confront pharmaceutical industry over excessive medicine prices On 1st April 2016, activists across the world are protesting against the greed that blocks access to essential medicines. April Fools’ Day is an appropriate day to highlight both the extortionate price of medicines and the lack of transparency around research […]

Read More

Declaration on Access to Medicines Handed to UN Chair of High-Level Panel

On Wednesday evening Justice Edwin Cameron described the fact that some people cannot access the medicines they need as deserving of moral outrage. Justice Cameron was speaking at an event co-hosted by the Department of Health and the United Nations Secretary General’s High Level Panel on Access to Medicines. A lack of access to essential medicines in both rich […]

Read More

TAC to participate in and picket outside United Nations hearings in Johannesburg

On Thursday the Treatment Action Campaign (TAC) together with partners Cape Mental Health, Advocates for Breast Cancer, People Living with Cancer, and SECTION27 will picket outside hearings held by the United Nations Secretary General’s High Level Panel on Intellectual Property and Access to Medicines (details below). We will urge the High Level Panel to place the […]

Read More

TAC’s Submission to the Private Healthcare Market Inquiry

Below is the Treatment Action Campaign’s oral submission to the Competition Commission’s Inquiry into the Private Healthcare Sector delivered on Wednesday 17th February by TAC Deputy Chairperson, Patrick Mdletshe. For more information on the private healthcare market inquiry visit SECTION27’s website.   — The TAC is a membership-based organisation that advocates for the rights and interests of […]

Read More

Speech by TAC’s Anele Yawa at Closing of Lung Conference

*This is a transcript of the speech given by General Secretary, Anele Yawa, at the closing ceremony of the 46th Union World Conference on Lung Health Delegates, friends, comrades, I thank you for the opportunity to address you. I am the General Secretary of the Treatment Action Campaign here in South Africa. We have more […]

Read More

Sanofi faces criticism at Lung Conference

CAPE TOWN, 4th DECEMBER 2015: Today, activists at the 46th Union World Conference on Lung Health demanded that pharmaceutical company Sanofi be held accountable for endangering failing to provide life-saving products to people and children living with TB and drug resistant TB in South Africa and across the world. Activists from the Treatment Action Campaign […]

Read More

Letter to DTI on Finalisation of the National IP Policy

On Friday 20th February TAC wrote to the Department of Trade and Industry, the Department leading on the finalisation of the National Intellectual Property (IP) Policy that affects medicine pricing. The policy has been in development for over six years now and crossed three ANC-led administrations. We did not receive a response on when the […]

Read More

#CoughUpTheTBMoney – Civil society calls for tripling of money for TB research

BARCELONA, 29th OCTOBER 2014: Today at the opening plenary of the 45th Conference on Lung Health in Barcelona, activists from across the globe called on governments to dramatically increase spending on research and development (R&D) for new treatments for tuberculosis (TB). Treatment options for people with multidrug-resistant TB (MDR-TB) are particularly challenging. Spending must be […]

Read More

Better DR-TB medicines desperately needed

24 March 2014 – World TB Day Currently available medicines for drug-resistant tuberculosis (DR-TB) require 18 to 24 months of treatment. This consists of a regimen of anything from 4 to more than 20 different pills daily, plus supplements and regular injections. These medicines can have serious side effects, including hearing loss and liver failure. […]

Read More

Unconscionable delay of TB drug trial

– Janssen must run a Phase III trial of bedaquiline urgently – More investment in TB drugs and diagnostics urgently needed The current standard of care for multi-drug resistant tuberculosis (MDR-TB) consists of poorly tested drugs with horrible side-effects. We are desperately in need of new properly tested TB drugs. Bedaquiline, made by the pharmaceutical […]

Read More